Skip to main content
. Author manuscript; available in PMC: 2015 May 19.
Published in final edited form as: Cancer. 2008 May 1;112(9):1905–1911. doi: 10.1002/cncr.23350

FIGURE 1.

FIGURE 1

Kaplan-Meier plots for (A) recurrence-free and (B) overall survival by HER-2 status. On univariate analysis, no significant difference was noted for recurrence-free survival (A). Univariate analysis revealed a non-significant trend in improved survival in patients with HER-2-positive disease compared with those with HER-2-negative disease.